-
1.
公开(公告)号:US4990507A
公开(公告)日:1991-02-05
申请号:US294743
申请日:1989-01-09
申请人: Takao Takaya , Hisashi Takasugi , Kimio Esumi , Atsushi Kuno , Hiroyoshi Sakai , Kazuhiro Maeda , Yoshie Sakamoto
发明人: Takao Takaya , Hisashi Takasugi , Kimio Esumi , Atsushi Kuno , Hiroyoshi Sakai , Kazuhiro Maeda , Yoshie Sakamoto
IPC分类号: C07D213/26 , C07D213/30 , C07D213/36 , C07D213/75 , C07D213/80 , C07D213/82 , C07D237/08 , C07D237/24 , C07D413/12 , C07D471/04 , C07D401/12 , A61K31/44
CPC分类号: C07D213/30 , C07D213/26 , C07D213/36 , C07D213/75 , C07D213/80 , C07D213/82 , C07D237/08 , C07D237/24 , C07D413/12 , C07D471/04
摘要: The invention relates to a pharmaceutical composition as a therapeutic agent for ischemic disease comprising a compound of the formula ##STR1## wherein R.sup.1 is carbamoyl substituted with morpholino (lower) alkyl, thiomorpholino(lower)alkyl or lower alkylamino(lower)alkyl; or ureido substituted with lower alkylamino(lower)alkyl; andR.sup.2 is phenyl substituted with nitro, andR.sup.4 is lower alkyl; orR.sup.2 is lower alkyl, andR.sup.4 is phenyl substituted with nitro;with proviso that R.sup.1 is carbamoyl substituted with thiomorpholino(lower)alkyl or lower alkylamino(lower)alkyl; or ureido substituted with lower alkylamino(lower)alkyl when R.sup.4 is lower alkyl; or its salt, as an active ingredient, in association with a pharmaceutically acceptable, substantially nontoxic carrier or excipient.
摘要翻译: 本发明涉及作为缺血性疾病治疗剂的药物组合物,其包含下式化合物其中R 1是被吗啉代(低级)烷基,硫代吗啉代(低级)烷基或低级烷基氨基(低级)烷基取代的氨基甲酰基) 或被低级烷基氨基(低级)烷基取代的脲基; R2是被硝基取代的苯基,R4是低级烷基; 或R 2为低级烷基,R 4为被硝基取代的苯基; 条件是R1是被硫代吗啉代(低级)烷基或低级烷基氨基(低级)烷基取代的氨基甲酰基; 或当R 4为低级烷基时被低级烷基氨基(低级)烷基取代的脲基; 或其盐作为活性成分,与药学上可接受的,基本上无毒的载体或赋形剂结合。
-
公开(公告)号:US4857527A
公开(公告)日:1989-08-15
申请号:US184195
申请日:1988-04-21
申请人: Takao Takaya , Hisashi Takasugi , Kimio Esumi , Atsushi Kuno , Hiroyoshi Sakai , Kazuhiro Maeda , Yoshie Sakamoto
发明人: Takao Takaya , Hisashi Takasugi , Kimio Esumi , Atsushi Kuno , Hiroyoshi Sakai , Kazuhiro Maeda , Yoshie Sakamoto
IPC分类号: C07D213/82
CPC分类号: C07D213/82
摘要: An N-containing heterocyclic compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl optionally substituted with hydroxy, halogen or a heterocyclic group, carboxy, esterified carboxy, carbamoyl optionally substituted with heterocyclic(lower)alkyl or lower alkylamino(lower)alkyl, N-containing heterocycliccarbonyl optionally substituted with lower alkyl, or ureido optionally substituted with lower alkylamino(lower)alkyl, andR.sup.3 is hydrogen or halogen;R.sup.2 is phenyl substituted with nitro, andX is .dbd.N--or ##STR2## in which R.sup.4 is lower alkyl or halo(lower)alkyl, or is taken together with R.sup.1 to form an N-containing heterocyclic group optionally substituted with oxo and lower alkylamino(lower)alkyl; orR.sup.2 is lower alkyl, andX is ##STR3## in which R.sup.4 is phenyl substituted with nitro; and a pharmaceutically acceptable salt thereof, processes for the preparation thereof and pharmaceutical (e.g. antihypertension) compositions comprising the same.
摘要翻译: 含有下式的杂环化合物:其中R 1为任选被羟基,卤素或杂环基取代的低级烷基,羧基,酯化羧基,任选被杂环(低级)烷基或低级烷基氨基(低级)烷基取代的氨基甲酰基 ,任选被低级烷基取代的含N杂环羰基或任选被低级烷基氨基(低级)烷基取代的脲基,R 3为氢或卤素; R 2为被硝基取代的苯基,X为= N-或其中R 4为低级烷基或卤代(低级)烷基),或与R 1一起形成任选被氧代取代的含氮杂环基 烷基氨基(低级)烷基; 或R2是低级烷基,X是其中R4是被硝基取代的苯基; 和其药学上可接受的盐,其制备方法和包含其的药物(例如抗高血压)组合物。
-